Johnson & Johnson price target raised to $166 from $159 at Barclays

5 days ago  · Barclays raised the firm’s price target on Johnson & Johnson to $166 from $159 and keeps an Equal Weight rating on the shares. The company r...


Install CouponFollow Chrome Extension   CouponFollow Extension

$166
OFF

Johnson & Johnson Price Target Raised To $166 From $159 At Barclays

3 weeks from now

5 days ago  · Barclays raised the firm’s price target on Johnson & Johnson to $166 from $159 and keeps an Equal Weight rating on the shares. The company r...

businessinsider.com

3%
OFF

Barclays Adjusts Johnson & Johnson's Price Target To $166 From …

3 weeks from now

5 days ago  · Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.3%): …

marketscreener.com

$166
OFF

Barclays Lifts Johnson & Johnson Stock Target To $166 - MSN

3 weeks from now

On Monday, Barclays (LON:BARC) analyst Matt Miksic increased the price target for Johnson & Johnson (NYSE:JNJ) shares, taking it up to $166 from the previous $166, while maintaining an …

msn.com

$166
OFF

Barclays Lifts Johnson & Johnson Stock Target To $166

3 weeks from now

6 days ago  · In other recent news, Johnson & Johnson's financial performance and future guidance have led Bernstein SocGen Group, Stifel, and BofA Securities to adjust their price …

investing.com

$166
OFF

Barclays Lifts Johnson & Johnson Stock Target To $166

3 weeks from now

6 days ago  · In other recent news, Johnson & Johnson's financial performance and future guidance have led Bernstein SocGen Group, Stifel, and BofA Securities to adjust their price …

investing.com

$166
OFF

Barclays Lifts Johnson & Johnson Stock Target To $166

3 weeks from now

6 days ago  · On Monday, Barclays (LON: BARC) analyst Matt Miksic increased the price target for Johnson & Johnson (NYSE: JNJ) shares, taking it up to $166 from the previous $166, while …

investing.com

$166
OFF

Johnson & Johnson: Target Price Consensus And Analysts …

3 weeks from now

Barclays Adjusts Johnson & Johnson's Price Target to $166 From $159, Keeps Equalweight Rating Jan. 27: MT Daiwa Adjusts Price Target on Johnson & Johnson to $150 From $170, …

marketscreener.com

$166
OFF

Barclays Adjusts Johnson & Johnson's Price Target To $166 From …

3 weeks from now

5 days ago  · -- Johnson & Johnson has an average rating of overweight and mean price target of $168.72, according to analysts polled by FactSet. Price: 151.73, Change: +4.91, Percent …

marketscreener.com

$160.00
OFF

Johnson & Johnson (JNJ) Gets A Hold From Barclays

3 weeks from now

Jan 16, 2025  · Barclays analyst Matt Miksic maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) today and set a price target of $160.00. The company’s shares closed …

businessinsider.com

$166
OFF

Barclays Lifts Johnson & Johnson Stock Target To $166

3 weeks from now

6 days ago  · In other recent news, Johnson & Johnson's financial performance and future guidance have led Bernstein SocGen Group, Stifel, and BofA Securities to adjust their price …

investing.com

$159
OFF

Barclays Adjusts Price Target On Johnson & Johnson To $159 From …

3 weeks from now

Jan 21, 2025  · Barclays Adjusts Johnson & Johnson's Price Target to $166 From $159, Keeps Equalweight Rating Jan. 27: MT US Regulator to Review Alvotech, Teva Pharmaceuticals' …

marketscreener.com

$175.00
OFF

Barclays Boosts Johnson & Johnson (NYSE:JNJ) Price Target To …

3 weeks from now

3 days ago  · Finally, Morgan Stanley reduced their price target on Johnson & Johnson from $175.00 to $163.00 and set an “equal weight” rating for the company in a report on Thursday, …

etfdailynews.com

$159.00
OFF

Johnson & Johnson (NYSE:JNJ) Price Target Cut To $159.00

3 weeks from now

Jan 21, 2025  · MarketBeat Week in Review – 01/13 - 01/17; Several other equities research analysts have also recently commented on JNJ. StockNews.com cut Johnson & Johnson from …

marketbeat.com

$160
OFF

Johnson & Johnson Price Target Lowered To $160 From $166 At BofA

3 weeks from now

Jan 17, 2025  · BofA analyst Tim Anderson lowered the firm’s price target on Johnson & Johnson to $160 from $166 and keeps a Neutral rating on the shares. The firm’s revised target, based …

businessinsider.com

$166.00
OFF

Barclays Lowers Johnson & Johnson (NYSE:JNJ) Price Target To …

3 weeks from now

Jan 23, 2025  · Bank of America cut their price target on Johnson & Johnson from $166.00 to $160.00 and set a “neutral” rating for the company in a research note on Friday, January 17th.

etfdailynews.com

$166
OFF

Barclays Lifts Johnson & Johnson Stock Target To $166

3 weeks from now

6 days ago  · Barclays lifts Johnson & Johnson stock target to $166. Open in App ...

investing.com

$160
OFF

BofA Securities Adjusts Johnson & Johnson Price Target To $160 …

3 weeks from now

Jan 17, 2025  · Barclays Adjusts Johnson & Johnson's Price Target to $166 From $159, Keeps Equalweight Rating ... Barclays Adjusts Johnson & Johnson's Price Target to $166 From …

marketscreener.com

$159
OFF

Barclays Maintains Equal-Weight On Johnson & Johnson, Raises …

3 weeks from now

5 days ago  · Barclays analyst Matt Miksic maintains Johnson Johnson (NYSE:JNJ) with a Equal-Weight and raises the price target from $159 to $166.

sahmcapital.com

$166
OFF

Johnson & Johnson: Target Price Consensus And Analysts …

3 weeks from now

5 days ago  · Barclays Adjusts Johnson & Johnson's Price Target to $166 From $159, Keeps Equalweight Rating Jan. 27: MT Daiwa Adjusts Price Target on Johnson & Johnson to $150 …

marketscreener.com

FAQs about Johnson & Johnson price target raised to $166 from $159 at Barclays Coupon?

What is Barclays' price target for Johnson & Johnson (JNJ)?

Read More on JNJ: Barclays raised the firm’s price target on Johnson & Johnson to $166 from $159 and keeps an Equal Weight rating on the shares. The company r... ...

Is Johnson & Johnson (JNJ) a good stock to buy?

On Monday, Barclays (LON:BARC) analyst Matt Miksic increased the price target for Johnson & Johnson (NYSE:JNJ) shares, taking it up to $166 from the previous $166, while maintaining an Equalweight rating on the stock. Miksic commented on the company's performance, noting that Johnson & Johnson delivered solid results in the fourth quarter. ...

Should you buy Miksic & Johnson (J&J)?

According to TipRanks, Miksic has an average return of 7.6% and a 60.90% success rate on recommended stocks. Currently, the analyst consensus on Johnson & Johnson is a Moderate Buy with an average price target of $169.60, a 16.99% upside from current levels. ...

What segments does Johnson & Johnson offer?

Johnson & Johnson (JNJ) Company Description: Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wound care markets. ...

Does Barclays expect organic sales growth in 2025?

The company anticipates organic sales growth to be between 2.0% and 3.0% for 2025, which aligns with both Barclays' estimates and the wider market consensus. For the 2025 EPS, management has set the guidance at $10.50 to $10.70, which not only meets but exceeds Barclays' estimates and aligns with general expectations. ...

How did Johnson & Johnson perform in the fourth quarter?

Miksic commented on the company's performance, noting that Johnson & Johnson delivered solid results in the fourth quarter. The pharmaceutical division, particularly the Oncology segment, showed strength that helped balance out weaker areas such as Electrophysiology (EP) and Surgery. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension